However, given the unprecedented speed of community transmission, the CP therapy did not assisted in achieving herd immunity to COVID-19, which requires a sufficient number of people in a population to have developed protective antibodies against SARS-CoV-2 through either vaccination or natural infection. The gene discussed is CP; the disease is infection.